Phase 2b Study of ALTO-100 in MDD
Study sponsor: Alto Neuroscience
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-09-05Actual
Enrollment · participants301Actual
Source updated2025-09-08Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.